BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29471546)

  • 1. Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis.
    Chaumette B; Kebir O; Pouch J; Ducos B; Selimi F; ; Gaillard R; Krebs MO
    Schizophr Bull; 2019 Jan; 45(1):247-255. PubMed ID: 29471546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylomic changes during conversion to psychosis.
    Kebir O; Chaumette B; Rivollier F; Miozzo F; Lemieux Perreault LP; Barhdadi A; Provost S; Plaze M; Bourgin J; ; Gaillard R; Mezger V; Dubé MP; Krebs MO
    Mol Psychiatry; 2017 Apr; 22(4):512-518. PubMed ID: 27113994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-sequencing of peripheral whole blood of individuals at ultra-high-risk for psychosis - A longitudinal perspective.
    Tan SMX; Yee JY; Budhraja S; Singh B; Doborjeh Z; Doborjeh M; Kasabov N; Lai E; Sumich A; Lee J; Goh WWB
    Asian J Psychiatr; 2023 Nov; 89():103796. PubMed ID: 37837946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of gene expression in maternal peripheral blood and monocytes during spontaneous preterm labor.
    Paquette AG; Shynlova O; Kibschull M; Price ND; Lye SJ;
    Am J Obstet Gynecol; 2018 Mar; 218(3):345.e1-345.e30. PubMed ID: 29305255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study.
    Lemos-Giráldez S; Vallina-Fernández O; Fernández-Iglesias P; Vallejo-Seco G; Fonseca-Pedrero E; Paíno-Piñeiro M; Sierra-Baigrie S; García-Pelayo P; Pedrejón-Molino C; Alonso-Bada S; Gutiérrez-Pérez A; Ortega-Ferrández JA
    Schizophr Res; 2009 Dec; 115(2-3):121-9. PubMed ID: 19786339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of peripheral expression of the YWHA genes during conversion to psychosis.
    Demars F; Kebir O; Marzo A; Iftimovici A; Schramm C; ; Krebs MO; Chaumette B
    Sci Rep; 2020 Jun; 10(1):9863. PubMed ID: 32555255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.
    Chung Y; Haut KM; He G; van Erp TGM; McEwen S; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; Cannon TD;
    Schizophr Res; 2017 Nov; 189():169-174. PubMed ID: 28245961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome.
    Zhang T; Xu L; Tang Y; Cui H; Wei Y; Wang J; Tang X; Li C; Wang J
    Psychol Med; 2018 Jun; 48(8):1274-1281. PubMed ID: 29173206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episodic memory functions in first episode psychosis and clinical high risk individuals.
    Greenland-White SE; Ragland JD; Niendam TA; Ferrer E; Carter CS
    Schizophr Res; 2017 Oct; 188():151-157. PubMed ID: 28143678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
    Radoeva PD; Fremont W; Antshel KM; Kates WR
    Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing psychosis risk traits in Africa: A longitudinal study of Kenyan adolescents.
    Mamah D; Musau A; Mutiso VN; Owoso A; Abdallah AB; Cottler LB; Striley CW; Walker EF; Ndetei DM
    Schizophr Res; 2016 Oct; 176(2-3):340-348. PubMed ID: 27522263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturalistic longitudinal study of at-risk mental state with a 2.4 year follow-up at a specialized clinic setting in Japan.
    Katsura M; Ohmuro N; Obara C; Kikuchi T; Ito F; Miyakoshi T; Matsuoka H; Matsumoto K
    Schizophr Res; 2014 Sep; 158(1-3):32-8. PubMed ID: 25034763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic variability in conversion to psychosis: novel findings from an innovative longitudinal methylomic analysis.
    Kebir O; Chaumette B; Krebs MO
    Transl Psychiatry; 2018 Apr; 8(1):93. PubMed ID: 29695761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis.
    Zheutlin AB; Jeffries CD; Perkins DO; Chung Y; Chekroud AM; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Seidman LJ; Walker EF; Woods SW; Tsuang M; Cannon TD
    Neuropsychopharmacology; 2017 Oct; 42(11):2188-2195. PubMed ID: 28186095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
    Smesny S; Milleit B; Schaefer MR; Hesse J; Schlögelhofer M; Langbein K; Hipler UC; Berger M; Cotter DR; Sauer H; McGorry PD; Amminger GP
    Schizophr Res; 2017 Oct; 188():110-117. PubMed ID: 28126360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.